Admin Posted May 5, 2012 Share Posted May 5, 2012 A recent post of this topic by Jim Marshall incorrectly reported that human trials of a combination of Zytiga (abiraterone acetate) and MDV3100 have been funded. In fact, while lab tests have shown that the combo could work, clinical trials in humans are planned, but not yet funded (as of 5 May 2012). See the corrected article here: http://advancedprostatecanceraustralia.ipbhost.com/index.php?/topic/453-clinical-trials-planned-to-test-abiraterone-and-mdv3100-combination/ (Thanks to Tony Maxwell) Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.